UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 3, 2025 HORIZON BANCORP, INC. (Exact name of registrant as specified in its charter) Indiana 000-10792 35-1562417 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 515 Franklin Street Michigan City, IN 46360 (Address of principal exe ...

Revenue Performance - NIKE, Inc. revenues for Q2 fiscal 2025 were $12.4 billion, down 8% from $13.4 billion in Q2 fiscal 2024[79] - NIKE Direct revenues for Q2 fiscal 2025 were $5.0 billion, down 13% from $5.7 billion in Q2 fiscal 2024, representing 42% of total NIKE Brand revenues[79] - NIKE Brand wholesale revenues for Q2 fiscal 2025 were $6.9 billion, down 3% from $7.1 billion in Q2 fiscal 2024[79] - NIKE Brand footwear revenues for Q2 fiscal 2025 were $7.7 billion, down 11% from $8.6 billion in Q2 fiscal 2024[84] - NIKE Brand apparel revenues for Q2 fiscal 2025 were $3.7 billion, down 1% from $3.8 billion in Q2 fiscal 2024[84] - NIKE Brand equipment revenues for Q2 fiscal 2025 were $544 million, up 14% from $479 million in Q2 fiscal 2024[84] - Converse revenues for Q2 fiscal 2025 were $429 million, down 17% from $519 million in Q2 fiscal 2024[84] - NIKE, Inc. revenues for Q2 fiscal 2025 were $12.4 billion, a 9% decrease on a currency-neutral basis compared to $13.4 billion in Q2 fiscal 2024, driven by declines in North America, EMEA, Greater China, and Converse[88] - NIKE Brand footwear revenues decreased 12% on a currency-neutral basis in Q2 fiscal 2025, with unit sales down 7% and lower ASP reducing revenues by 5 percentage points[88] - NIKE Direct revenues for Q2 fiscal 2025 were $5.0 billion, a 14% decrease on a currency-neutral basis, with NIKE Brand Digital sales declining 21% and comparable store sales down 2%[88] - North America revenues for Q2 fiscal 2025 were $5.179 billion, an 8% decrease on a currency-neutral basis compared to $5.625 billion in Q2 fiscal 2024[104] - Converse revenues for Q2 fiscal 2025 were $429 million, a 17% decrease on a currency-neutral basis compared to $519 million in Q2 fiscal 2024[104] - Footwear revenues decreased by 14% to $3.236 billion in Q2 FY2025, with a 14% decline to $6.448 billion for the first six months of FY2025[107] - Apparel revenues increased by 1% to $1.693 billion in Q2 FY2025, with a 4% decline to $3.024 billion for the first six months of FY2025[107] - NIKE Direct revenues decreased by 15% to $2.313 billion in Q2 FY2025, with a 13% decline to $4.664 billion for the first six months of FY2025[107] - EMEA revenues decreased by 10% on a currency-neutral basis, with NIKE Direct revenues down 20% due to a 32% decline in digital sales[115] - Greater China revenues decreased by 8% to $1.711 billion in Q2 FY2025, with a 6% decline to $3.377 billion for the first six months of FY2025[117] - EMEA revenues decreased 11% on a currency-neutral basis, with NIKE Direct revenues down 17% due to a 29% decline in digital sales, partially offset by 2% comparable store sales growth[119] - Greater China revenues decreased 11% on a currency-neutral basis, with NIKE Direct revenues down 7% due to an 8% decline in comparable store sales and a 4% decline in digital sales[120] - APLA revenues decreased 2% on a currency-neutral basis, with NIKE Direct revenues down 4% due to an 8% decline in digital sales[125] - Converse revenues decreased 18% on a currency-neutral basis, with unit sales down 12% and ASP down 6% due to higher discounts[130] Gross Margin and Profitability - Gross margin for Q2 fiscal 2025 decreased by 100 basis points to 43.6%, primarily due to higher discounts and changes in channel mix[79] - Gross margin for Q2 fiscal 2025 was 43.6%, a 100 basis points decrease compared to 44.6% in Q2 fiscal 2024, primarily due to lower NIKE Brand ASP and higher other costs[88][95] - Gross margin in North America was flat, impacted by lower ASP due to product mix, channel mix changes, and higher discounts[111] - Gross margin expanded by 140 basis points in EMEA, primarily due to lower product costs and reduced warehousing and logistics expenses[119] - Gross margin contracted by approximately 200 basis points due to lower ASP, higher logistics costs, and unfavorable foreign currency exchange rates[134] Expenses and Costs - Total selling and administrative expenses for Q2 fiscal 2025 were $4.005 billion, a 3% decrease compared to $4.146 billion in Q2 fiscal 2024, with operating overhead expenses down 5%[90][93] - Selling and administrative expenses decreased by 2% primarily due to lower operating overhead expenses[134] - Corporate loss before interest and taxes decreased 6% to $565 million, primarily due to unallocated general and administrative expenses[131] - Global Brand Divisions' loss before interest and taxes decreased 3% due to lower operating overhead expense, partially offset by higher demand creation expense[126] - Corporate's loss before interest and taxes increased by $30 million in Q2 FY2025 compared to Q2 FY2024[134] - Corporate's loss before interest and taxes decreased by $79 million in the first six months of FY2025 compared to the same period in FY2024[134] Regional Performance - North America EBIT decreased by 10% to $1.371 billion in Q2 FY2025, with a 13% decline to $2.587 billion for the first six months of FY2025[106] - Europe, Middle East & Africa EBIT decreased by 10% to $831 million in Q2 FY2025, with a 13% decline to $1.623 billion for the first six months of FY2025[106] - Greater China EBIT decreased by 27% to $375 million in Q2 FY2025, with a 16% decline to $877 million for the first six months of FY2025[106] - Total NIKE Brand EBIT decreased by 18% to $1.904 billion in Q2 FY2025, with a 19% decline to $3.589 billion for the first six months of FY2025[106] - Footwear revenues decreased 12% on a currency-neutral basis in EMEA, with unit sales down 12% and ASP per pair flat[119] - Apparel revenues decreased 10% on a currency-neutral basis in EMEA, with unit sales down 11% and higher ASP contributing 1 percentage point of growth[119] - Greater China footwear revenues decreased 14% on a currency-neutral basis, with unit sales down 9% and lower ASP reducing revenues by 5 percentage points[120] Cash Flow and Shareholder Returns - NIKE returned approximately $1.6 billion to shareholders in Q2 fiscal 2025 through share repurchases and dividends[79] - Cash provided by operations was $1,443 million in the first six months of FY2025, down from $2,751 million in the same period of FY2024[144] - Cash used in investing activities was $240 million in the first six months of FY2025, compared to an inflow of $875 million in the same period of FY2024[145] - Cash used in financing activities was $3,070 million in the first six months of FY2025, slightly lower than $3,151 million in the same period of FY2024[146] - The company repurchased 27.9 million shares for $2,254 million in the first six months of FY2025 under its $18 billion share repurchase program[147] - As of November 30, 2024, the company had $9.8 billion in cash and equivalents and short-term investments[152] - Obligations under endorsement contracts totaled $15.9 billion as of November 30, 2024, with $1.9 billion payable within 12 months[154] Inventory and Other Financial Metrics - Inventories as of November 30, 2024, were $8.0 billion, a 6% increase compared to May 31, 2024[79] - Other (income) expense, net decreased to $8 million in Q2 fiscal 2025 from $75 million in Q2 fiscal 2024, primarily due to unfavorable foreign currency conversion gains and losses[96][97] - Effective tax rate for the first six months of fiscal 2025 was 18.7%, compared to 15.2% in the same period of fiscal 2024, due to one-time benefits in fiscal 2024[100][101]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): January 3, 2025 Securities registered pursuant to Section 12(b) of the Act: CYTOSORBENTS CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-36792 98-0373793 (Commission File Number) (I.R.S. Employer Identification No.) (State or other jurisdiction of incorporation) 3 ...

CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): January 2, 2025 INTEGRAL AD SCIENCE HOLDING CORP. (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Delaware 001-40557 83-0731995 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 12 E 49th Street, 20th Floor New York, NY 10017 (Addre ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ____________ Commission File Number 001-13341 Titan Pharmaceuticals, Inc. (Exact name of registrant as specified in its charter) | Delaware | 94-3171940 | | --- | --- | | (State or other jurisdiction ...

Sabine Royalty Trust Exhibit 99.1 SABINE ROYALTY TRUST ANNOUNCES MONTHLY CASH DISTRIBUTION FOR JANUARY 2025 News Release | | Net to Trust Sales | | | | | --- | --- | --- | --- | --- | | | Volumes (a) | | | Average Price (a) | | | | | Oil | Gas | | | Oil (bbls) | Gas (Mcf) | (per bbl) | (per Mcf) | | Current Month | 76,247 | 1,617,815 | $67.70 | $1.61 | | Prior Month | 68,183 | 1,536,640 | $71.76 | $1.39 | (a) Sales volumes are recorded in the month the Trust receives and identifies the related royalty incom ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-3498 Taylor Devices, Inc. (Exact name of registrant as specified in its charter) | New York | 16-0797789 | | --- | --- | | (State ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ____________________________________________________________________________________________ FORM 10-Q ____________________________________________________________________________________________ (Mark One) xQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 23, 2024 OR oTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANG ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Quarter Ended November 24, 2024, or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition period for _________ to _________. LIFECORE BIOMEDICAL, INC. (Exact name of registrant as specified in its charter) Delaware 94-3025618 (State or other jurisdict ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F Title of each class Trading Symbol(s) Name of each exchange on which registered Class A Ordinary Shares, par value $0.00003 per share GMM The Nasdaq Stock Market LLC (Nasdaq Capital Market) OR (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(B) OR 12(G) OF THE SECURITIES EXCHANGE ACT OF 1934 ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, ...